Lundbeckfond Ventures (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:Copenhagen

Lundbeckfond Ventures is an evergreen life science venture fund investing in life science companies primarily in Europe, up to €50 million annualy.

Lundbeckfonden Ventures aims to support the group's activities and operating independently from the Lundbeckfonden’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Average round investment:33.06M USD
Average number per year:2.1
Distribution: 2025 (3)2024 (2)2023 (4)2022 (1)2021 (2) See the entire list
Mostly invests in: Denmark Denmark (17) Biotech (23)
See the entire list

Showing 3 of 23 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Lundbeckfond Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Lundbeckfond Ventures

Name Criteria
France AdBio partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, France, Spain
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
United Kingdom Circularity Capital LLP
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Electronics, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Denmark, Sweden
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Creadev
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
France Red River West
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Bioqube Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Denmark, Netherlands, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Day One Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Sweden, France, Spain
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Spain BBVA
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, Electronics, Hardware, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France, Spain
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Germany Bosch Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services, Electronics, Hardware, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Sweden, France, Spain
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
France Mutuelles Impact
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United Kingdom LifeArc Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top